Research Advances in Treatment of Myeloma Nephropathy-Review.
10.7534/j.issn.1009-2137.2017.02.056
- Author:
Xiao-Ping ZHANG
1
;
Zu-Yao XIA
1
;
Bao-An CHEN
2
;
Chong GAO
3
Author Information
1. Department of Hematology and Oncology, Zhongda Hospital,Medical School, Southeast University, Nanjing,210009, Jiangsu Province, China.
2. Department of Hematology and Oncology, Zhongda Hospital,Medical School, Southeast University, Nanjing,210009, Jiangsu Province, China. E-mail:cba8888@hotmail.com.
3. Department of Hematology and Oncology, Zhongda Hospital,Medical School, Southeast University, Nanjing,210009, Jiangsu Province, China.E-mail:gaochong@hotmail.com.
- Publication Type:Journal Article
- From:
Journal of Experimental Hematology
2017;25(2):613-616
- CountryChina
- Language:Chinese
-
Abstract:
Myeloma nephropathy is a common complication in patients with myltiple myeloma (MM) that causes high morbidity. In the majority of cases, renal impairment is caused by the accumulation and precipitation of light chains, which form casts in the distal tubules, resulting in renal obstruction. This review discusses the recent advances on its treatment, so as to provide reference for clinical treatment of MM induced-renal failure.
